Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto
- Address
- lock Available on a paid plan
Neurology and Parkinson’s Disease Research
At Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto in Milan, clinical trials in Nervous System Diseases focus on Parkinson’s disease and multiple system atrophy. This research is aimed at evaluating new treatment options and understanding long-term safety and effectiveness for people living with progressive movement disorders.
- Studies in early-stage Parkinson’s disease and related neurodegenerative conditions
- Research assessing the safety and tolerability of emerging therapies for movement disorders
- Clinical testing designed to improve symptom control and disease management
The site’s Centro Parkinson e parkinsonismi supports research that may help refine care for patients with complex neurological disease.
Autoimmune and Rheumatology Trials
A major part of the research portfolio covers Immune System Diseases and immune system processes, with studies in rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, juvenile psoriatic arthritis, and polymyalgia rheumatica. These trials are generally focused on testing new therapies and comparing treatment strategies to improve disease control.
- Trials in adult and pediatric arthritis and related inflammatory conditions
- Studies evaluating treatment effectiveness in rheumatoid arthritis and psoriatic arthritis
- Research on optimizing care for children with chronic inflammatory joint disease
The research at this hospital also includes work on treatment adjustment, remission maintenance, and long-term safety in autoimmune disease.
Sjögren’s Syndrome and Systemic Autoimmunity
Several trials at the site address Sjögren’s syndrome, systemic lupus erythematosus, diffuse cutaneous systemic sclerosis, and broader connective tissue diseases. The goal is to evaluate therapies that may reduce systemic inflammation, improve symptoms, and support better long-term outcomes in complex autoimmune disorders.
- Research in Sjögren’s disease targeting both systemic features and patient-reported symptoms
- Studies in systemic lupus erythematosus examining disease activity and response to treatment
- Trials in systemic sclerosis and overlapping connective tissue disease conditions
This area reflects a strong focus on therapies that may offer more precise control of autoimmune disease activity.
Pediatric Rheumatology and Childhood Inflammatory Disease
The site has an active program in pediatric rheumatology, especially juvenile idiopathic arthritis, juvenile psoriatic arthritis, and related childhood inflammatory conditions. These studies aim to improve treatment choices for young patients while balancing effectiveness, safety, and quality of life.
- Trials focused on children and adolescents with chronic inflammatory arthritis
- Studies exploring better ways to maintain remission and reduce medication burden
- Research comparing established treatments with newer options for pediatric disease control
This pediatric research strengthens the site’s role in advancing care for younger patients with long-lasting rheumatic disease.
Musculoskeletal Pain and Bone-Related Research
Clinical studies in Musculoskeletal Diseases include chronic low back pain, postmenopausal osteoporosis, and metastatic osteosarcoma. The purpose of these trials is to assess new approaches for pain relief, bone health, and disease management in both common and complex musculoskeletal conditions.
- Research on persistent back pain and symptom relief
- Studies of bone-targeted treatment approaches in osteoporosis
- Clinical evaluation of supportive treatment in metastatic bone cancer
At Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto, this work connects orthopedic expertise with broader clinical research in musculoskeletal care.
Inflammatory Skin and Related Immune Conditions
Additional trials involve skin and connective tissue diseases, including Behçet’s disease and inflammatory conditions with skin or mucosal involvement. These studies are designed to evaluate new therapies and long-term treatment approaches for diseases that can affect multiple organs and day-to-day functioning.
- Studies in Behçet’s disease with emphasis on controlling oral and systemic symptoms
- Research on inflammatory disorders with skin and connective tissue involvement
- Trials aiming to improve safety and sustained disease control over time
The mix of dermatologic and systemic research highlights the site’s broad interest in immune-mediated disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 15 of 52 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 48 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
- 1Novartis Pharma AG3active
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG9trials
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto
lock Showing 1 of 45 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Long-term Extension Study of Apremilast in Pediatric Patients with Behçet’s Disease-Associated Oral Ulcers or Juvenile Psoriatic Arthritis | Amgen Inc. | Phase III | Recruiting | Oct 2019 | — |
IMP list
lock Showing 1 of 52 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ianalumab | 5 | Unknown | 2022-08-04 | 2025-01-02 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.